High Content Screening Market Growth, Demand and Challenges of the Key Industry Players

1
Global High Content Screening Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global High Content Screening Market Research
Report 2022-2027 According to the latest report
by IMARC Group, titled "High Content Screening
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2022-2027,"
the global high content screening market size
reached US 1.1 Billion in 2021. High content
screening (HCS) refers to an advanced approach of
cell-based screening in drug discovery and
systems biology that utilizes visualization tools
to gather quantitative data from cell
populations. It involves the usage of
quantitative data analysis and automated imaging
in a high-throughput format. Also known as high
content analysis, it employs multicolor fluorescen
ce imaging to analyze several biochemical and
physical characteristics of the sample cells. As
a result, this analytical method of automated
microscopy assists in complex multivariate drug
profiling and toxicity studies. Request for a
PDF sample of this report https//www.imarcgroup.
com/high-content-screening-market/requestsample

4
Report Description and Highlights
Report Description
Global High Content Screening Market
Trends The global market is majorly driven by
the increasing incidences of chronic
neurodegenerative diseases, such as Parkinsons
and Alzheimers. This has led to the growing need
for affordable and effective drug discovery
systems on the global level, which is providing
an impetus to the market growth. HCS is widely
preferred by professionals as this method of
microscopy aids in analyzing the potential
toxicity of chemicals and complex substances in a
resource-efficient manner. The market is further
driven by continual developments in informatics
solutions and imaging instruments. Moreover,
numerous key players are also introducing
innovative HCS equipment in the market that are
equipped with software platforms and artificial
intelligence (AI) systems in an attempt to
improve the visualization capabilities of the
systems. Some of the other factors contributing
to the market growth include the growing
geriatric population, the advent of automated
systems for analyzing cell separation and
scalability, and extensive research and
development (RD) activities conducted by major
players. On account of the aforementioned
factors, the market is anticipated to grow at a
CAGR of 8.7 during 2022-2027. View Report TOC,
Figures and Tables https//www.imarcgroup.com/hig
h-content-screening-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product
• Instruments
• Cell Imaging and Analysis Systems
• Flow Cytometers
• Consumables
• Reagents Assay Kits
• Microplates
• Other Consumables
• Software
• Services
• Accessories
•  
• Breakup by End-User
• Pharmaceutical and Biotechnology Companies
• Academic and Government Institutes
• Contract Research Organizations (CROs)

6
Report Description and Highlights
Report Description

•  
• Breakup by Application
• Target Identification and Validation
• Primary Screening and Secondary Screening
• Toxicity Studies
• Compound Profiling
• Other Applications
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Becton
• Dickinson and Company
• Bio-Rad Laboratories Inc.
• Biotek Instruments Inc.
• Danaher Corporation
• GE Healthcare
• Merck Millipore
• Perkinelmer Inc.
• Tecan Group Ltd.
• Thermo Fisher Scientific
• Yokogawa Electric Corporation
•  

8
Key Questions Answered in the Report
Report Description

• How has the global high content screening market
  performed so far and how will it perform in the
  coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the
  global high content screening market?
• What is the breakup of the market based on the
  product?
• What is the breakup of the market based on the
  application?
• What is the breakup of the market based on the
  end-user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global high content
  screening market and who are the key players?
• What is the degree of competition in the
  industry?
•  

9
Table of Contents
Report Description
1   Preface2   Scope and Methodology     2.1  
 Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3   Executive Summary4  
Introduction    4.1    Overview    4.2    Key
Industry Trends5   Global High Content Screening
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6   Market Breakup by Product     6.1  
 Instruments        6.1.1 Market Trends       
6.1.2 Major Types             6.1.2.1 Cell
Imaging and Analysis Systems             6.1.2.2
Flow Cytometers        6.1.3 Market Forecast   
6.2    Consumables        6.2.1 Market Trends 
      6.2.2 Major Types             6.2.2.1
Reagents Assay Kits             6.2.2.2
Microplates             6.2.2.3 Others       
6.2.3 Market Forecast    6.3    Software       
6.3.1 Market Trends        6.3.2 Market
Forecast          Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/high-conten
t-screening-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us